Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Follow-On Biologics: Defeat For Waxman, Win For Health Reform

Executive Summary

Rep. Henry Waxman, D-Calif., can perhaps take some comfort in the fact that his defeat on follow-on biologics means his broader health reform legislation may have a greater chance of passage

You may also be interested in...



PhRMA Donations To Political Campaigns Reflect Makeup Of Congress, Group Says

The skewing of the Pharmaceutical Research and Manufacturers of America’s PAC political campaign donations in favor of Democrats reflects the current makeup of Congress rather than an attempt to influence the outcome of the 2010 midterm elections, the organization maintains.

PhRMA Donations To Political Campaigns Reflect Makeup Of Congress, Group Says

The skewing of the Pharmaceutical Research and Manufacturers of America’s PAC political campaign donations in favor of Democrats reflects the current makeup of Congress rather than an attempt to influence the outcome of the 2010 midterm elections, the organization maintains.

Many Blue Dogs Go Against House Bill Despite Concessions On Public Option

Blue Dog Democrats' "no" votes make House health reform vote a close one: Could more conservative Senate Finance Committee bill be ultimate template for reform?

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS051326

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel